Amorphous dispersions of epigallocatechin gallate are herein described. In addition, pharmaceutical compositions comprising such dispersions and methods of treating diseases with such dispersions and pharmaceutical compositions are also described.L'invention concerne des dispersions amorphes de gallate d'épigallocatéchine. De plus, l'invention concerne des compositions pharmaceutiques comprenant de telles dispersions et des procédés de traitement de maladies avec de telles dispersions et compositions pharmaceutiques.
